Less Is More: Developments in Nanotechnology for Antirestenosis Therapies

Area of Science:

• Biomedical Engineering
• Cardiovascular Research
• Nanomedicine

Background:

• Vascular interventions like angioplasty and stenting face challenges including thrombosis and poor vessel patency.
• Endothelial damage during procedures leads to neointimal hyperplasia, increasing risks of thrombosis and restenosis.
• Current drug delivery methods lack cell-type selectivity, hindering endothelium repair.

Purpose of the Study:

• To review current localized vascular drug delivery methods.
• To explore emerging nanoscale therapeutic and excipient strategies for cardiovascular interventions.
• To recommend future research directions for advancing vascular disease treatment with nanotechnology.

Main Methods:

• Analysis of existing literature on localized vascular drug delivery.
• Examination of current and emerging nanoscale drug delivery systems.
• Review of therapeutic agents and excipients used in vascular interventions.

Main Results:

• Current endovascular techniques restore acute blood flow but have limitations in long-term efficacy.
• Nanoscale drug delivery holds potential for improved efficacy and reduced off-target effects.
• Targeted delivery can overcome limitations of non-selective drug distribution.

Conclusions:

• Nanotechnology-based drug delivery can redefine cardiovascular interventions.
• Targeted nanoscale approaches promise enhanced long-term vessel patency and reduced complications.
• Further research in nanomedicine is crucial for advancing vascular disease treatment.